- Dr. Marty Makary, Trump’s FDA nominee, emphasized scientific integrity, affordable drug pricing, and addressing toxic food additives during his Senate confirmation hearing.
- He pledged to tackle chronic illnesses linked to toxic additives, aligning with the Trump administration’s Make America Healthy Again (MAHA) agenda.
- Makary criticized the Biden administration for bypassing advisory committees in COVID-19 booster approvals, advocating for open scientific discourse.
- He focused on food safety, calling for evidence-based policies to address hazardous chemicals and pesticides impacting children’s health.
- Makary’s bipartisan support and commitment to FDA efficiency suggest he is poised for confirmation, with a Senate vote scheduled for March 13.
Dr. Marty Makary, President Donald Trump’s nominee to lead the U.S. Food and Drug Administration (FDA), appears poised for confirmation after a Senate hearing this week in which he emphasized his commitment to scientific integrity, affordable drug pricing, and addressing toxic food additives.
The Johns Hopkins surgeon, known for his criticism of COVID-19 vaccine mandates and government overreach during the pandemic, faced tough questions from the Senate Health, Education, Labor, and Pensions (HELP) Committee but emerged as a unifying figure with bipartisan support.
Makary’s hearing highlighted his dedication to the Make America Healthy Again (MAHA) agenda, a cornerstone of the Trump administration’s health policy. He pledged to tackle chronic illnesses linked to toxic food additives, a growing concern for American families. “Half of our nation’s children are sick,” Makary said during the hearing. “Nobody has been doing anything meaningful on this front until we have gotten new momentum and enthusiasm from Secretary Kennedy and President Trump to finally address the root causes of these diseases.”
Makary, a prominent critic of censorship during the COVID-19 pandemic, reiterated his commitment to open scientific discourse. He drew attention to the Biden administration’s decision to bypass advisory committee meetings when authorizing COVID-19 boosters, a move he called out as inconsistent with scientific rigor. When pressed by Sen. Patty Murray (D-Wash.) to reinstate a postponed FDA vaccine advisory committee meeting, Makary responded, “You can ask the Biden administration that chose not to convene the committee meeting for the COVID vaccine booster.” […]
— Read More: www.naturalnews.com
